Lupin informs about disclosure

08 Jul 2020 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Lupin has informed that the Company has voluntarily recalling its Metformin Hydrochloride Extended- Release Tablets USP, 500mg and 1000mg products in the US. This recall is being conducted out of an abundance of caution in line with the ongoing interaction with the US Food and Drug Administration on NDMA impurity levels. The associated press release in the US is enclosed for reference.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2347.45 15.70 (0.67%)
25-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1794.85
Dr. Reddys Lab 1301.90
Cipla 1243.90
Zydus Lifesciences 903.60
Lupin 2347.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×